Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous Ultrasound-Guided Core Needle Biopsy: Comparison of 16-Gauge versus 14-Gauge Needle and the Effect of Coaxial Guidance in 1065 Breast Biopsies - A Prospective Randomized Clinical Noninferiority Trial.
Gruber I, Oberlechner E, Heck K, Hoopmann U, Böer B, Fugunt R, Gall C, Hartkopf AD, Helms G, Hoffmann SM, Ott C, Röhm C, Stäbler A, Wallwiener D, Brucker SY, Hahn M. Gruber I, et al. Among authors: helms g. Ultraschall Med. 2020 Oct;41(5):534-543. doi: 10.1055/a-1014-2628. Epub 2019 Dec 2. Ultraschall Med. 2020. PMID: 31791085 Clinical Trial. English.
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse.
Hartkopf AD, Banys M, Meier-Stiegen F, Hahn M, Röhm C, Hoffmann J, Helms G, Taran FA, Wallwiener M, Walter C, Neubauer H, Wallwiener D, Fehm T. Hartkopf AD, et al. Among authors: helms g. Breast Cancer Res Treat. 2013 Apr;138(2):509-17. doi: 10.1007/s10549-013-2470-9. Epub 2013 Mar 15. Breast Cancer Res Treat. 2013. PMID: 23494674
High intensity focused ultrasound (HIFU) for the treatment of symptomatic breast fibroadenoma.
Hahn M, Fugunt R, Schoenfisch B, Oberlechner E, Gruber IV, Hoopmann U, Roehm C, Helms G, Taran FA, Hartkopf AD, Warzecha H, Wiesinger B, Brucker SY, Boeer B. Hahn M, et al. Among authors: helms g. Int J Hyperthermia. 2018;35(1):463-470. doi: 10.1080/02656736.2018.1508757. Epub 2018 Sep 11. Int J Hyperthermia. 2018. PMID: 30204024 Free article.
Evaluation of sonographic detectability of different markers within an in vitro simulation model of the axilla.
Guergan S, Hoopmann U, Roehm C, Boeer B, Fugunt R, Helms G, Seller A, Marx M, Oberlechner E, Hartkopf A, Preibsch H, Brucker S, Wallwiener D, Hahn M, Gruber IV. Guergan S, et al. Among authors: helms g. Arch Gynecol Obstet. 2021 Sep;304(3):839-848. doi: 10.1007/s00404-021-06085-9. Epub 2021 Jun 17. Arch Gynecol Obstet. 2021. PMID: 34142225 Free PMC article.
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial.
Schwentner L, Helms G, Nekljudova V, Ataseven B, Bauerfeind I, Ditsch N, Fehm T, Fleige B, Hauschild M, Heil J, Kümmel S, Lebeau A, Schmatloch S, Schrenk P, Staebler A, Loibl S, Untch M, Von Minckwitz G, Liedtke C, Kühn T. Schwentner L, et al. Among authors: helms g. Breast. 2017 Feb;31:202-207. doi: 10.1016/j.breast.2016.11.012. Epub 2016 Nov 24. Breast. 2017. PMID: 27889596 Clinical Trial.
177 results